Wednesday, 21 May

12.30-13.30 Satellite symposium
13.00-13.30 ESCI Members meeting

13.30-15.00 Session 3.1. Lipid Dysfunction in Metabolic Disorders

Chairs: Marcin Krawczyk, Paula Macedo

13.30-13.50 Adipose Tissue Dysfunction: A Central Driver of MASLD, by Amalia Gastaldelli (Pisa, Italy)
13.50-14.10 Clinical Presentation of LAL-Deficiency, a Rare Dislipidemia with Liver Involvement, by Livia Pisciotta (Genoa, Italy)
14.10-14.30 Statins and nonalcoholic fatty liver disease in the era of precision medicine, by Fabio Nascimbeni (Modena, Italy)
14.30-14.45 Oral presentation (abstract 115)

14.45-15.00 Oral presentation (abstract 107)

15.00-15.30 Coffee-break

15.30-17.00 Session 3.2. Microbiota-Liver Interactions in Metabolic Health

Chairs: Federico Gatto, Edoardo Giannini

15.30-16.00 Microbiome Changes and Syndrome of Bacterial Overgrowth in Patients
with Dyslipidemia, by Khrystyna Kvit (Lviv, Ukraine)

16.00-16.30 Probiotic Lactobacillus rhamnosus Mitigates Ductular Reaction in Mcpip1-Deficient Mice
via Modulation of Gut-Liver Crosstalk, by Jerzy Kotlinowski (Krakow, Poland)

16.30-16.45 Oral presentation (abstract 74)

16.45-17.00 Oral presentation (abstract 181)

17.00-17.30 Opening ceremony

17.30-18.30 Opening lecture

18.30 Welcome drink

Thursday, 22 May

09.00-10.30 Session 3.3. Complexities in Liver and Metabolic Disorders

Chairs: Piero Portincasa, Harshitha Shanmugam

09.00-09.30 MetALD: Challenges of coexisting metabolic dysfunction and alcohol toxicity in the liver, by Gyorgy Baffy (Boston, USA)

09.30-10.00 Linking MASH to Chronic Kidney Disease, by Sonia Najjar (Ohio, USA)

10.00-10.15 Oral presentation (abstract 109)

10.15-10.30 Oral presentation (abstract 207)

10.30-11.00 Coffee-break

11.00-12.30 Session 3.4. Gut-Liver Axis and Therapeutics

Chairs: Jerzy Kotlinowski, Michał Żorniak

11.00-11.30 Next Generation Probiotics and MASLD, by Giovanni Sarnelli (Napoli, Italy)

11.30-12.00 Genetic Profiling for Carbohydrate Maldigestion in Irritable Bowel Syndrome, by Mauro D’Amato (Bari, Italy)

12.00-12.15 Oral presentation (abstract 63)

12.15-12.30 Oral presentation (abstract 187)

12.30-13.30 Poster session

13.00-14.00 Satellite symposium
13.30-14.30 Lunch

14.30-16.00 Session 3.5. Hormonal and Lifestyle Modulators in Obesity and Liver Health 

Chairs: Mauro D’Amato, Diego Ferone

14.30-15.00 Hormonal, Metabolic, and Gastrointestinal Motility Changes in Subjects
with Obesity Undergoing Sleeve Gastrectomy, by Gabriella Garruti (Bari, Italy)                                       

15.00-15.30 Navigating the Metabolic Crossroads: Personalized Lifestyle Insights from EU Projects
on Obesity and Subclinical Liver Function, by Harshitha Shanmugam and Mohamad Khalil (Italy)

15.30-15.45 Oral presentation (abstract 173)

15.45-16.00 Oral presentation (abstract 105)

 
16.00-17.00 Satellite symposium
17.00-18.00 Satellite symposium
17.00-18.00 Poster session and coffee-break

20.00 Congress dinner

Friday, 23 May

08.00-09.00 Satellite symposium
 

09.00-10.30 Session 3.6. Lipid Regulation and Energy Balance

Chairs: Silvia Vilares Conde, Luca Miele

09.00-09.30 Pancreatic Steatosis: The Fatty Time Bomb Fueling Diabetes or More?, by Michał Żorniak (Gliwice, Poland)

09.30-10.00 New Framework for the Diagnosis, Staging, and Management of Obesity in Adults, by Sara Becerril (Pamplona, Spain)

10.00-10.15 Oral presentation (abstract 52)

10.15-10.30 Oral presentation (abstract 143)

10.30-11.00 Coffee-break

11.00-12.30 Session 3.7. Personalized Approaches and Sex-Specific Insights

Chairs: Gabriella Garutti, Livia Pisciotta

11.00-11.30 Sex Matters in Obesity and Longevity: Unveiling Metabolic Disparities, by Maria Paula Macedo (Lisbon, Portugal)

11.30-12.00 MASLD Therapies on the Horizon: Shaping the Future of Liver  Disease Management, by Luca Miele (Rome, Italy)

12.00-12.15 Oral presentation (abstract 200)

12.15-12.30 Oral presentation (abstract 225)

12.30-14.00 Poster session and lunch
13.00-14.00 Satellite symposium
14.00-17.00 Closing lectures and session | ESCI Awards Ceremony 2025